Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Notable Labs Inc.

NTBL
Current price
0.45 USD -0.027 USD (-5.62%)
Last closed 0.48 USD
Company
ISIN unknown
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 4 617 241 USD
Yield for 12 month -94.35 %
1Y
3Y
5Y
10Y
15Y
NTBL
21.11.2021 - 28.11.2021

Notable Labs, Ltd., a clinical-stage platform therapeutics company, develops predictive precision medicines for patients with cancer. The company, through its proprietary Predictive Precision Medicines Platform (PPMP), bio-simulates a cancer treatment and predicts, whether or not the patient will clinically respond to their actual treatment. Its PPMP is designed to identify and select clinically responsive patients prior to their treatment and enables fast-track therapeutic development in this patient population. The company's pipeline includes Volasertib, a potent Polo-like kinase 1 (PLK-1) inhibitor to induce cell cycle arrest and apoptosis in various cancer cells; and Fosciclopirox, a pro-drug of ciclopirox for acute myeloid leukemia. Notable Labs, Ltd. was incorporated in 2014 and is headquartered in Foster City, California. Address: 320 Hatch Drive, Foster City, CA, United States, 94404

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

9 USD

P/E ratio

Dividend Yield

Current Year

+310 000 USD

Last Year

+8 000 USD

Current Quarter

+2 000 USD

Last Quarter

+1 000 USD

Current Year

+113 000 USD

Last Year

-1 154 000 USD

Current Quarter

-62 000 USD

Last Quarter

+1 000 USD

Key Figures NTBL

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -15 116 000 USD
Operating Margin TTM -269000 %
PE Ratio
Return On Assets TTM -106.09 %
PEG Ratio
Return On Equity TTM -464.25 %
Wall Street Target Price 9 USD
Revenue TTM 313 000 USD
Book Value 0.74 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM 8 000 USD
Earnings per share -1.09 USD
Diluted Eps TTM -1.09 USD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics NTBL

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History NTBL

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:35
Payout Ratio
Last Split Date 17.10.2023
Dividend Date

Stock Valuation NTBL

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 7.4129
Price Sales TTM 14.7516
Enterprise Value EBITDA -0.8318
Price Book MRQ 0.6425

Financials NTBL

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators NTBL

For 52 weeks

0.45 USD 10.08 USD
50 Day MA 0.57 USD
Shares Short Prior Month 537 665
200 Day MA 1.24 USD
Short Ratio 12.82
Shares Short 509 855
Short Percent 8.18 %